Market Size of Uropathy Treatment Industry
Study Period | 2018 - 2028 |
Base Year For Estimation | 2021 |
Forecast Data Period | 2024 - 2028 |
CAGR | 4.20 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Uropathy Treatment Market Analysis
The Uropathy Treatment Market is expected to register a CAGR of 4.2% during the forecast period. Uropathy/obstructive uropathy may occur due to kidney stones, bladder stones, blood clots, uterine cancer, colon cancer, cervical cancer, and problems with the nerves that supply the bladder. Treatment available for management of uropathy includes stents, catheters and drugs.
According to a study published in Advances in Urology, Kidney stone disease is an increasing urological disorder of human health which is affecting about 15% of the world population and it affects all age groups but occurs more frequently in men than in women within the age of 20–49 years. Moreover, during lifetime, approximately 7% of women and 13% of men will develop a kidney stone.
Increasing prevalence of kidney stone, urological disorders and rising incidence of cancer and technological advancement in catheters and stents are the key driving factors in uropathy treatment market.